These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 23697606

  • 21. Comparison across Three Hybrid Lipid-Based Drug Delivery Systems for Improving the Oral Absorption of the Poorly Water-Soluble Weak Base Cinnarizine.
    Joyce P, Yasmin R, Bhatt A, Boyd BJ, Pham A, Prestidge CA.
    Mol Pharm; 2017 Nov 06; 14(11):4008-4018. PubMed ID: 28950059
    [Abstract] [Full Text] [Related]

  • 22. Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug.
    Kossena GA, Charman WN, Boyd BJ, Porter CJ.
    J Pharm Sci; 2005 Mar 06; 94(3):481-92. PubMed ID: 15619248
    [Abstract] [Full Text] [Related]

  • 23. Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion.
    Birru WA, Warren DB, Han S, Benameur H, Porter CJ, Pouton CW, Chalmers DK.
    Mol Pharm; 2017 Mar 06; 14(3):580-592. PubMed ID: 27936778
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M, Przyklenk KH, Richtberg A, Baumann W, Dressman JB.
    Eur J Pharm Biopharm; 2014 Nov 06; 88(3):795-806. PubMed ID: 25195981
    [Abstract] [Full Text] [Related]

  • 26. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH, Hanley T, Porter CJ, Larson I, Boyd BJ.
    J Pharm Pharmacol; 2010 Jul 06; 62(7):856-65. PubMed ID: 20636873
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
    Lee KW, Porter CJ, Boyd BJ.
    J Pharm Sci; 2013 Feb 06; 102(2):565-78. PubMed ID: 23242691
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
    Vithani K, Hawley A, Jannin V, Pouton C, Boyd BJ.
    Eur J Pharm Biopharm; 2018 Sep 06; 130():236-246. PubMed ID: 29981444
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
    Miller JM, Beig A, Carr RA, Spence JK, Dahan A.
    Mol Pharm; 2012 Jul 02; 9(7):2009-16. PubMed ID: 22632106
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Using the polymer partitioning method to probe the thermodynamic activity of poorly water-soluble drugs solubilized in model lipid digestion products.
    Boyd BJ, Porter CJ, Charman WN.
    J Pharm Sci; 2003 Jun 02; 92(6):1262-71. PubMed ID: 12761815
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.